COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q2 2025

Type / Class
Debt / NOTE 1.500% 4/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q2 $0 $0 -$199,168,381 0
2025 Q1 $144,739,249 $199,168,381 +$10,151,140 97.95% 12
2024 Q4 $137,699,979 $187,201,296 +$172,568 97.0% 17
2024 Q3 $154,545,602 $121,262,001 +$954,484 78.5% 22
2024 Q2 $156,533,812 $140,568,054 -$17,205,821 73.5% 25
2024 Q1 $181,571,812 $140,461,793 -$6,883,576,128 64.11% 24
2023 Q4 $211,845,000 $122,230,738 +$6,224,860 56.72% 27
2023 Q3 $199,445,755 $122,375,975 -$6,439,666 61.25% 22
2023 Q2 $209,844,000 $132,818,459 -$6,673,832 61.85% 24
2023 Q1 $218,350,500 $155,131,944 -$47,005 70.28% 28
2022 Q4 $218,899,500 $145,364,935 -$2,270,074 65.75% 29
2022 Q3 $216,906,500 $172,535,541 +$28,191,315 79.13% 28
2022 Q2 $186,825,000 $122,124,320 +$1,758,183 65.32% 24
2022 Q1 $166,304,000 $163,025,279 -$4,675,525 99.29% 22
2021 Q4 $167,332,000 $185,926,528 -$24,706,873 110.56% 23
2021 Q3 $189,572,000 $209,789,973 +$18,768,511 110.88% 26
2021 Q2 $172,807,000 $177,229,715 +$177,229,715 102.35% 25